Seguridad y eficacia de bajar la presion sanguinea en diabeticos comparando con no diabeticos Ontarget

Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes Subgroup Analyses From the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) | DocGuide

We sought to determine whether the blood pressure (BP) levels at which cardiovascular (CV) protection is achieved differ between diabetic and nondiabetic patients from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). BACKGROUNDGreater absolute benefits of BP reductions have been claimed for diabetic as compared with nondiabetic patients

Published with Blogger-droid v2.0.3